IHS Chemical Week

Regions :: Southeast Asia :: Singapore

Reliance Buys Biotech Firm

10:16 AM MDT | July 30, 2007 | Chemical Week Editorial Staff

Reliance Life Sciences (RLS: Mumbai), part of the Reliance Group, says it will acquire a controlling stake in biopharmaceutical company GeneMedix (Newmarket, U.K.). RLS will invest ₤32.1 million ($62.7 million) in GeneMedix over the next five years, enabling RLS to launch its biosimilars in Europe and the U.S. GeneMedix has operations in Europe, and stock exchange listings in London and Singapore. RLS’s investment will be made in two segments. An initial investment of approximately ₤14.6 million will be made for the purchase of 1.16 billion shares, or a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa